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Abstract
Objective: To analyze the short and long term safety and efficacy of ureteroscopic evaluation and management of chronic
unilateral hematuria.
Methods: We retrospectively reviewed patients with chronic unilateral hematuria from 1987 to 2008. The distal to middle
ureter was evaluated with a semi-rigid ureteroscope without a guidewire. Subsequently, the flexible ureteroscope was
advanced into the upper ureter to the renal pelvis using a low-pressure automated irrigant system (Uromat
TM). Lesions
identified ureteroscopically were treated with diathermy fulguration.
Results: One hundred and four (56 male, 48 female) patients were identified, with a median age of 37 (14–80) years and
median follow-up of 139 (34–277) months. The median preoperative duration of gross hematuria was 5 (1–144) months.
Endoscopic findings included 61 (56%) minute venous rupture (MVR; a venous bleeding without clear abnormalities), 21
(20%) hemangioma (vascular tumor-like structure), 3 (3%) varix (tortuous vein), 1 (1%) calculus and 18 (17%) no lesions. The
incidence of ‘‘no lesions’’ was less in the recent 12 years (9%) than the first 10 years (27%), while the incidence of MVR
increased from 40 to 66% (p,0.05). All patients were treated endoscopically. Immediate success rate was 96% (100% in the
recent 12 years). Long-term recurrent gross hematuria rate was 7%. Six resolved spontaneously and only 1 required
ureteroscopy, revealing a different bleeding site.
Conclusion: Ureteroscopy and diathermy fulguration is highly useful for evaluation and treatment of chronic unilateral
hematuria. Sophisticated technique and improved instrumentation contributes to a better outcome.
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Introduction
Chronic unilateral hematuria poses a diagnostic and therapeutic
dilemma. [1,2,3] It is characterized by intermittent or continuous
gross hematuria that cannot be diagnosed with standard radiologic
and hematologic tests. [4] Cystoscopy can reveal that hematuria is
renal in origin, and may demonstrate lateralization to one or both
ureteral orifices. Chronic unilateral hematuria is also known as
unilateral essential hematuria. [1] Historically, some patients have
underwent nephrectomy for hemostasis or possible malignancy.
[5]
To avoid unnecessary nephrectomy, several investigators have
reported the utility of ureteroscopy for evaluating and treating this
disease. [1,2,3,4,6,7] Initially, there were some limitations such as
size of instrumentation, clarity of vision and modality of
hemostasis. Literature reviews reported successful outcomes were
between 58 and 87%. [8]
To achieve higher successful treatment rates, we have been
refining our instrumentation and technique. Over the years, we
have learned that the small tips are very important treating this
entity including when and how to use guidewire, the control of
irrigation pressure, the order of ureteroscopic observation and
hemostasis modality.
We report our technique and results over a 22-year experience.
Methods
Preoperative Diagnostic Work-up
Between 1987 and 2008, 104 patients with chronic unilateral
hematuria were referred to our hospital for ureteroscopic
evaluation. Radiology and hematology tests were normal and
failed to reveal the source of hematuria. Cystoscopy revealed the
hematuria from 1 side in all patients except 1 patient who had
bilateral bleeding. Evaluation included cystoscopy, intravenous
pyelogram (IVP), ultrasonography, computerized tomography
(CT). Angiography was performed in cases when arteriovenous
malformation (AVM) or arteriovenous fistula (AVF) was suspected
on CT scan (shunt) or ultrasound (mosaic pattern). Hematology
tests included prothrombin, partial thromboplastin and bleeding
times and complete blood count. Series of urine cytology and urine
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tract infection documented by urine analysis and urine culture
(n=1). AVM and AVM that were diagnosed by angiography were
excluded as these were treated by embolization by interventional
radiologist (n=1).
Technique
Following the prophylactic cefazolin administration, the proce-
dure is initiated with cystoscopy under general anesthesia. Our
technique has been evolved over 22 years, and is summarized in
Table 1. Specifically, as smaller endoscopic instrumentation
became available, the need for dilation of the ureteral orifice
and/or peel-away sheath was eliminated. Our irrigation system
changed from static to dynamic pressure controlled system,
Uromat
TM (Karl Storz, Tuttlingen, Germany).
Since November 1997 (II period), our technique has been
fixed. Following cystoscopy, the distal to middle portion of the
ureter (L4–5 level) is inspected using a 6.9 Fr semi-rigid
ureteroscope without a guidewire. Semi-rigid ureteroscope also
gently dilates the ureteral orifice and helps the following flexible
ureteroscope insertion. Subsequently, an initial guidewire is
placed under the fluoroscopic guidewire to the level of
endoscopic inspection. A special caution should be taken not
to advance a guidewire beyond the middle ureter (L4–5 level) in
order to avoid an inadvertent injury to the collecting system.
Semi-rigid ureteroscope is removed and flexible ureteroscope
((AUR-7, (size: 7.2 Fr, working channel: 3.6 Fr) or URF-P3
(6.9 Fr, 3.6 Fr)) is passed over the guidewire into the ureter
under fluoroscopic guidance, again with a caution not to
advance a guidewire beyond the middle ureter. The guidewire
is then removed. The proximal ureter and collecting system are
inspected with flexible ureteroscope. Systemic evaluation of
entire collecting system should be performed in order: upper,
middle, and lastly lower to avoid an inadvertent urothelial
bleeding. If the flexible ureteroscope is passed initially into the
lower pole, the shaft of the flexible ureteroscope can cause
bleeding from the upper pole infundibulum and can mislead the
examiner. A biopsy is performed with a 3 Fr cup forceps
though the ureteroscope if malignancy is suspected. Continuous
irrigation is maintained through the working channel of the
ureteroscope in a lowest flow pressure (40 mm Hg) with
Uromat
TM (Karl Storz). Irrigant containing iodinated contrast
material (17%) is used to outline the collecting system for
radiographic monitoring. When a source of bleeding it not
clear, Uromat is discontinued and ureteroscopy is performed
without irrigation.
Once lesions are identified, they are cauterized by 2 or 3 Fr
(30 W) Bugbee electrode through the working channel of flexible
ureteroscope. At the end of procedure, a single-J stent (6 Fr in
diameter, external stent) is placed for a several days only in cases
which required ureteral dilation. Follow-up includes urinalysis at 4
weeks and every 3 months in the first year and every year post-
surgery. Renal ultrasound was performed every clinical visit. In
cases of malignancy, urine cytology was obtained every 3 months
and ureteroscopy was performed every 3 months in the first 2
years, every 6 months in 3 to 5 years post-surgery and every year
thereafter. All patients completed a minimum follow-up of two
years.
Okayama University Hospital institutional review board
approval was obtained for this study. Patients are consented at
admission before surgery with written documents for study.
The statistical analysis was performed by StatView software. P
values were derived from the chi-square test or Fisher’s exact test
(categorical variables) or Student’s t test (continuous variables). All
statistical tests were two-sided.
Results
One hundred and four patients were identified, with a
median age of 37 (range 14–80) years (Table 2). Median follow-
up was 139 (34–277) months. Patients had gross hematuria
prior to surgery for 5 (range 1–144) months. Sixty-eseven (64%)
patients had bleeding in the left, 37 (36%) in the right and 1
(1%) in both sides. Prior to ureteroscopy at our institution, 39
(38%) of patients had received hemostatic medication (carbazo-
chrome sodium sulfonate and/or amstat) either orally or
intravenously. 17 (16%) of patients had underwent the
instillation of silver nitrate into the renal pelvis at outside
hospitals. One patient (1%) had undergone ureteroscopy with
an unsuccessful outcome at an outside hospital. The proportion
of patients treated with silver nitrate prior to referral to our
Table 1. The changes of ureteroscopic techniques.
I II
I-a I-b I-c
(July 1987,) (April 1991,) (March 1994,) (November 1997,)
Dilation of ureteral orifice (+)( +)( 2)( 2)
Peel-away sheath (+)( 2)( 2)( 2)
Endoscope URF AUR-9 Multi-scope Multi-scope
(Diameter, (13.2, 5.1 Fr) AUR-8 (7/12, 4.0 Fr) (6/7.4, 4.0 Fr)
working channel) AUR-9 (8.5, 2.5 Fr) QQ
(9.8, 3.6 Fr) AUR-9,8 AUR-7
(7.2, 3.6 Fr)
URF-P3
(6.9, 3.6 Fr)
Control of the pressure of the
irrigating fluid
Static Dynamic (Uromat
TM) Dynamic (Uromat
TM) Dynamic (Uromat
TM)
doi:10.1371/journal.pone.0036729.t001
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Table 3).
The entire collecting system was completely inspected in all
patients. The lesions identified included 61 (56%) minute venous
rupture (a small venous bleeding without clear abnormalities,
MVR), 21 (20%) hemangioma (vascular tumor-like structure), 3
(3%) varix (tortuous vein), 1 (1%) calculus. The incidence of ‘‘no
lesions’’ was less in the recent 12 years or II period (9%) than
the first 10 years or I period (29%, p,0.05), while the incidence
of MVR increased from 40 to 66% (p,0.05). All patients were
treated successfully endoscopically (Table 4). The major
endoscopic findings are demonstrated in Figure 1.
The location of MVR were documented in 59/62 (95%) cases
(Figure 2). The site of MVR located primarily in upper pole calices
(29 (48%)), followed by lower pole calices (20 (33%)) and middle
pole calyces (5 (8%)). Bleeding from multiple sites was identified in
3 unilateral cases and 1 bilateral case. The location of MVR did
not differ significantly between I and II periods.
Immediate success rate, defined as absence of gross hematuria
within a month post-surgery, was 100/104 (96%). Four required
another surgery within a month, one underwent a second
ureteroscopy and three underwent percutaneous nephroscopic
electrocautery because they were too large to treat ureteroscopi-
cally (All three were in I-period). No immediate treatment failure
was identified in the recent 12 years.
7/104 (7%) experienced recurrent gross hematuria, defined as a
bleeding more than one month after successful initial treatment.
The incidence of recurrent gross hematuria has decreased to 3%
(2/68) from 12% (5/40), although it is not significant (p=0.1).
Only 1 required ureteroscopy for hemostasis at 2 year post-
surgery, revealing a different bleeding site (right upper and lower
pole) from the original (right middle pole). Other 6 cases stopped
bleeding spontaneously without ureteroscopy.
Adverse events include 11 (10%) extravasations and 4 (4%)
pyelonephritis (Table 5). All were treated conservatively: patients
noted to have extravasation were treated with ureteral stent and
pyelonephritis was treated with antibiotics. The incidence of
those adverse events decreased over the two study periods
(p,0.05).
Discussion
Chronic unilateral hematuria is also known as unilateral
essential hematuria, [5] lateralizing essential hematuria, [6,9]
and benign lateralizing hematuria. [10]
More than 200 cases of chronic unilateral hematuria have been
reported to date [8,11] but there has been only a few reports in the
last 5 years. [2,12,13] This report provides the history of the
diagnosis and treatment of chronic unilateral hematuria. Our
series has the longest-follow-up with the largest series of patients
from a single institution. Lano et al. reported 54 patients with
chronic unilateral hematuria in 1979. [5] Since ureteroscopy was
not yet available that time, ancillary studies such as renal
arteriography, renal biopsy, and repeated excretory urography
and cystoscopic examinations were performed, but were not
helpful in establishing a cause. However, the advent of endoscopy
has changed the approach to diagnosis of chronic unilateral
hematuria. The etiology has been revealed to include not only
hemangioma but minute venous rupture, varix or others. We have
been working on this entity since 1987 and published our initial
report in 1990. Flexible endoscopy has also revolutionized the
treatment of chronic unilateral hematuria. The traditional
management of recurrent, prolonged bleeding has been bed-rest,
blood transfusion, the instillation of silver nitrate into the renal
pelvis. The instillation of silver nitrate into the renal pelvis had
been the most common conservative management of chronic
unilateral hematuria, first described by Diamond. Ten mL of silver
nitrate (0.25 to 1%) was instilled into the upper collecting system in
the original articles. In our series, 17 (16%) of patients underwent
the instillation of silver nitrate into the renal pelvis at outside
hospitals prior to ureteroscopy. Silver nitrate is often associated
with a number of serious side effects, including sepsis, interstitial
nephritis, anuria, pyonephrosis, and ureteral strictures. [14] Due
to our continuous warning of these side effects in our society, the
number of silver nitrate treatment decreased from 34 to 6% over
the years in our series. It should be contraindicated for the
treatment of chronic unilateral hematuria. More aggressive
measures have included total and partial nephrectomy. In
contrast, Lano et al. reported that only 56% continued to have
intermittent or persistent hematuria with conservative observation.
[5] In our series, 6/7 (86%) patients with recurrent gross
hematuria had spontaneous resolution. It seems that partial/total
nephrectomy should be the avoided.
The recent introduction of flexible ureteroscopy has allowed
successful nephron-sparing endoscopic treatment with minimum
complications. The major endoscopic finding was MVR (56%) in
our series. MVR appears as a bleeding without clear abnormalities
typically from the tip of the papilla. In contrast, hemangiomas
appear as either small red or bluish spots at the tip or base of a
papilla. [3] Our results echoes those reported in other reports.
[15,16] However, there are a few reports where hemangioma was
the major endoscopic findings. [3,10] The second most common
Table 2. Patient characteristics.
No. patients 104
No. men/women 56/48
Median age (range) 37 (14–80)
No. left/right/bilateral 67/37/1
Median duration of hematuria (range) (mos) 5 (1–144)
Median follow-up (range) (mos) 139 (34–277)
doi:10.1371/journal.pone.0036729.t002
Table 3. Treatment prior to ureteroscopy at outside hospital.
N (%) Hemostatic medicine Silver nitrate Ureteroscopy None Total
Period I 15 (38) 13 (33) 0 12 (30) 40 (100)
Period II 24 (36) 4 (6) 1 (1) 38 (55) 64 (100)
Total (N=104) 39 (38) 17 (16) 1 (1) 47 (45) 109 (100)
p-value (I vs II) 1 ,0.001 1 ,0.05 N/A
doi:10.1371/journal.pone.0036729.t003
Chronic Unilateral Hematuria
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different results may be related to the genetic or ethnic make-up of
our study populations. There were no major (sepsis, blood
transfusions, death) complications in our series. Uromat
TM plays
an important role by controlling the pressure of irrigation fluid the
lowest level (40 mm Hg) to prevent pyelonephritis and extravasa-
tion.
There are several pearls for evaluation and treatment of chronic
unilateral hematuria.
1. The meticulous endoscopic technique: Examination should be
performed in order: upper, middle, and lastly lower because if
the flexible ureteroscope is passed first into the lower pole, the
shaft of the endoscope can bruise the urothelium. Prior to
flexible ureteroscopy, inadvertent injury should be avoided. In
our recent technique, the guidewire is never advanced into the
collecting system beyond the point of endoscopic inspection.
After semi-rigid ureteroscopy at the distal and middle ureter,
the guidewire is kept at the site where semi-rigid ureteroscopy
has been completed under fluoroscopy. Guidewire can be
easily lost in this technique so that special caution is required.
We also have to keep in mind that the guidewire can go up
easily to the collecting system. If that happens, we should
regard MVR in the upper pole as an inadvertent injury.
2. The control of irrigation pressure: Minute venous bleeding is
such a delicate lesion. The increased intraluminal pressure
during ureteroscopy can easily seal a small venous rupture.
Literature review revealed that no lesion was seen in 16% of
cases of chronic unilateral hematuria. Even in the most recent
report of chronic unilateral hematuria, there were 5 (21%)
patients with no lesions at the time of ureteroscopy. All 5 had
no recurrent bleeding post-surgery. [2] Other series reported
similar results. [2,10] The venous-caliceal communication may
have been closed by tamponade effect of the increased
intraluminal pressure. However, for a diagnostic purpose,
gentle irrigation is crucial in this technique. In most reports,
irrigation is maintained by gravity and manual syringe
injection. [2,5,6] In our recent series, maintenance of a
minimum irrigation pressure is maintained at the lowest
(40 mm Hg) with Uromat
TM throughout the procedure. It is
suggested that the utilization of this device have contributed to
a decreased incidence of ‘‘no lesion’’ and increased incidence of
MVR. We also create a negative pressure with syringe
aspiration through the working channel when bleeding is
unclear. With those techniques, our rate of ‘‘no lesion’’ has
decreased over time from 29% to 9%.
3. The improvement of endoscopic instruments: Endoscope has
been miniaturized. The size of semi-rigid ureteroscope has
changed from 13.2 Fr to 6 Fr and that of flexible ureteroscope
has changed from 9.8 Fr to 6.9 Fr. Illumination has also
improved to obtain a better endoscopic vision. New generation
flexible ureteroscope with two deflectable segments allows
complete examination of the collecting system, especially of the
lower calyx. Digital ureteroscope is a major advance in
endourology and has superior visualization compared with a
conventional fiber ureteroscope. We believe that it will help the
diagnosis and the treatment of chronic unilateral hematuria.
4. Semi-rigid ureteroscopy prior to flexible ureteroscopy: Al-
though flexible ureteroscope is miniaturized, the flexible
ureteroscope will not pass the ureteral orifice without dilation
in most of the Japanese population. Therefore, we routinely
utilize semi-rigid ureteroscope prior to flexible ureteroscope.
The elimination of ureteral dilation is important in the
diagnosis of chronic unilateral hematuria because dilation of
the ureter prior to ureteroscopy creates iatrogenic change in
the ureter. The use of semi-rigid ureteroscope achieves both
diagnosistic ureteroscopy and gentle dilation of the ureter.
5. A patient preparation: It is extremely difficult to evaluate
bleeding without gross hematuria at the time of ureteroscopy.
A patient should be very active prior to surgery if he does not
have an ongoing gross hematuria. For example, a patient is
asked to climb a few flights of stairs prior to ureteroscopy.
We utilize 2 or 3 Fr electrode for hemostasis. Diathermy
fulguration has been used in more than 80% of reported
endoscopic treatments. [8] It is safe, inexpensive, widely available
Table 4. Endoscopic findings in patients with chronic unilateral hematuria.
N (%) Minute venous rupture Hemangioma Varix Calculus No lesion
Period I(N=40) 16 (40) 10 (25) 1 (3) 1 (2) 12 (29)
Period II (N=64) 45 (66) 11 (16) 2 (3) 0 6 (9)
Total (N=104) 61 (56) 21 (20) 3 (3) 1 (1) 18 (17)
p-value (I vs II) ,0.005 0.47 1 0.38 ,0.05
doi:10.1371/journal.pone.0036729.t004
Figure 1. Major endoscopic findings. Minute venous rupture (MVR:
a bleeding without clear abnormalities).
doi:10.1371/journal.pone.0036729.g001
Chronic Unilateral Hematuria
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Holmium:YAG or Nd: YAG laser treatment has been also
reported. [2,3,6,13] Literature review revealed successful outcome
was between 58 and 87% but did not discuss the superiority of
laser vs. electrocautery treatment modality. [8] However, success-
ful rates of diathermy fulguration is as high as 90% in our series
(100% in the last 12 years). In addition, the expense of diathermy
fulguration is much less in Japan than Holmium:YAG or Nd:
YAG laser ablation is the cost. [8] With those reasons, we favor
diathermy fulguration over Holmium:YAG or Nd: YAG laser
ablation for the treatment of chronic unilateral hematuria.
The pathogenesis of MVR or hemangioma is poorly under-
stood. Venous hypertension, renal pelvic inflammation, infection,
thrombosis, trauma from calculi and secondary arterial renal
venous hypertension are all possible explanations.
8,19 Further
investigation of calyceal urodynamics or renal venous hemody-
namic may be necessary.
In conclusion, chronic unilateral hematuria has been a difficult
problem of diagnosis and treatment with minimum complications.
Ureteroscopy is highly useful for evaluation and treatment of
chronic unilateral hematuria. In our series, the major endoscopic
finding was minute venous rupture (56%). The advent of
miniaturized ureteroscopes with technical improvement and
experience has contributed to a more accurate etiology and
treatment of chronic unilateral hematuria. Diathermy fulguration
is inexpensive and effective treatment modality for the treatment
of this entity.
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Figure 2. Locations of minute venous rupture (MVR). I period: Multiple lesions: 1 (6%) (Rt. upper pole and lower pole calices). Not
documented:2 (13%). II period: Multiple lesions: 3 (7%) Case 1 (rt. upper pole and middle pole calices), Case 2 (rt. Upper pole and lower pole calices),
Case 3 (a bilateral case: rt. upper pole, lt. upper and lower pole calices). Not documented:1 (2%).
doi:10.1371/journal.pone.0036729.g002
Table 5. Recurrent gross hematuria and adverse events.
N( % )
Immediate treatment
failure
Incidence of recurrent
gross hematuria
Outcome of recurrent
gross hematuria Adverse events
Spontaneous
resolution URS Extravasation Pyelonephritis
I (N=40) 4 (10)* 5 (12) 4 (10)** 1 (2)*** 9 (22) 4 (10)
II (N=64) 0 2 (3) 2 (3)
# 02 ( 3 ) 0
p-value (I vs. II),0.05 0.1 0.2 0.38 ,0.05 ,0.05
*One required second ureteroscopy. Other 3 underwent successful percutaneous nephroscopic electrocautery.
**Recurrent gross hematuria occurred at 1 month, 1, 2 and 2 year post-surgery, respectively. All resolved spontaneously.
***One had a bleeding from a different site at 2 years post-surgery. Therefore this does not seem to be a treatment failure.
#Recurrent gross hematuria occurred in 8 and 10 year post-surgery, respectively. Both resolved spontaneously.
doi:10.1371/journal.pone.0036729.t005
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